期刊文献+

大鼠尾加压素II收缩大鼠肺动脉干与蛋白激酶C通路相关性研究

大鼠尾加压素II收缩大鼠肺动脉干与蛋白激酶C通路相关性研究
下载PDF
导出
摘要 目的研究大鼠尾加压素-Ⅱ(RUII)收缩大鼠离体肺动脉干环与细胞信号转导通路蛋白激酶C通道的关系。方法从雄性Sprague—Dauley大鼠中分离出肺动脉干,切成3—4mm的血管环,用RUII(10nmol/L)预收缩血管达坪台期后,加入蛋白激酶C通道阻断剂H-7,制备H-7(0.1-100μmol/L)浓度一效应舒张曲线,最后分别计算EC50和Emax。结果H-7呈浓度依赖性舒张大鼠RUII预收缩的肺动脉干-log[EC50]=5.26±0.36,Emax=(97.21±17.86)%。结论细胞信号转导通路蛋白激酶C通道的激活参与大鼠尾加压素-Ⅱ收缩大鼠肺动脉干效应。 Objective The aim of our study was to investigate the influence of protein kianse C inhibition on rat urotensin Ⅱ induced vasoconstriction. Methods The train mmeus pulmanalis was dissected from the nude Sprague - Dawley rat, artery ring width was 3 - 4mm. Inhibitor of protein kinase C channel, H- 7(0.1 - 100/μmol/L) were added into medium after rat urotensin Ⅱ( 10nmol/L)indueed vasoconstriction had reached plateau to construct the relaxant concentration- response curves and their EC50 and Emax. Results H - 7 caused concentration - dependent relaxations of rat urotensin Ⅱ preeontracted arteries [ - log[EC50] = 5.26 ± 0.36. Emax = (97.21 ± 17.86)% of the response to 10 nmoL/L rat urotensin Ⅱ]. Conclusion Rat UII induced rat main pulmonary artery contraction is related to the activation of protein kinase C signal transduciton pathway.
出处 《浙江临床医学》 2007年第1期3-4,共2页 Zhejiang Clinical Medical Journal
基金 浙江省教育厅 科学基金20020468号
关键词 尾加压素-Ⅱ 蛋白激酶C 肺动脉干 urotensin Ⅱ protein kinase C tnmcus pulmonalis
  • 相关文献

参考文献11

  • 1Pearson D,Shively JE,Clark BR,et al.Urotensin Ⅱ:a somatostatin-like peptide in the caudal neurosecretory system of fishes.Proc Natl Acad Sci USA,1980,77(8):5021~5024.
  • 2Coulouarn Y,Lihrmann I,Jegou S,et al.Cloning of the cDNA encoding the urotensin Ⅱ precursor in frog and human reveals intense expression of the urotensin Ⅱ gene in motoneurons of the spinal cord.Proc Natl Acad Sci USA,1998,95(26):15803~15808.
  • 3Liu Q,Pong SS,Zeng Z,et al.Identification of urotensin Ⅱ as the endogenous ligand for the orphan G-protein-coupled receptor GPR14.Biochem Biophys Res Commun,1999,266(1):174~178.
  • 4Ames RS,Sarau HM,Chambers JK,et al.Human urotensin-Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GPR14.Nature,1999,401:282~286.
  • 5Sauzeau VL,Mellionnec E,Bertoglio J,et al.Human urotensin Ⅱ-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase.Circ Res,2001,88(11):1102~1104.
  • 6Watanabe T,Pakala R,Katagiri T,et al.Synergistic effect of urotensin Ⅱ with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells.Circulation,2001,104(1):16~18.
  • 7CHEN Ya-hong,ZHAO Ming-wu,YAO Wan-zhen,et al.The signal transduction pathway in the proliferation of airway smooth muscle cells induced by urotensin Ⅱ.Chinese Medical Journal,2004,117(1):37~41.
  • 8陈少贤,薛必成,龚永生,范小芳,胡良刚,陈彦凡,王良兴.大鼠尾加压素Ⅱ收缩大鼠离体肺主动脉环与MAPK相关(英文)[J].中国病理生理杂志,2003,19(10):1365-1368. 被引量:8
  • 9MacLean MR,Alexander D,Stirrat A,et al.Contractile responses to human urotensin-Ⅱ in rat and human pulmonary arteries:effect of endothelial factors and chronic hypoxia in the rat.Br J Pharmacol,2000,130(2):201~204.
  • 10Bottrill FE,Douglas SA,Hiley CR,et al.Human urotensin-Ⅱ is an endothelium-dependent vasodilator in rat small arteries.Br J Pharmacol,2000,130(8):1865~1870.

二级参考文献11

  • 1[1]Pearson D, Shively JE, Clark BR, et al. Urotensin-II: a somatostatin-like peptide in the caudal neurosecretory system of fishes[J]. Proc Natl Acad Sci USA, 1980,77(8):5021-5024.
  • 2[2]Coulouarn Y, Lihrmann I, Jegou S, et al. Cloning of the cDNA encoding the urotensin-II precursor in frog and human reveals intense expression of the urotensin-II gene in motoneurons of the spinal cord[J]. Proc Natl Acad Sci USA ,1998,95(26):15803-15808.
  • 3[3]Liu Q, Pong SS, Zeng Z, et al. Identification of urotensin-II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14[J]. Biochem Biophys Res Commol/Lun,1999, 266(1):174-178.
  • 4[4]JD, Liu WS, Glover GI, Wilson S, et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14[J]. Nature,1999,401(6750):282-286.
  • 5[5]Rossowski WJ, Cheng BL, Taylor JE, et al. Human urotensin-II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists[J]. Eur J Pharmacol,2002,438(3):159-170.
  • 6[6]Watanabe T, Pakala R, Katagiri T, et al. Synergistic effect of urotensin-II with serotonin on vascular smooth muscle cell proliferation[J]. J Hypertens,2001,19(12):2191-2196.
  • 7[7]Ishihata A, Tasaki K, Katano Y, et al. Involvement of p44/42 mitogen-activated protein kinases in regulating angiotensin II- and endothelin-1-induced contraction of rat thoracic aorta[J]. Eur J Pharmacol,2002,445(3):247-256.
  • 8[8]Maguire JJ, Kuc RE, Davenport AP, et al. Orphan-receptor ligand human urotensin-II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1[J]. Br J Pharmacol,2000,131(3):441-446.
  • 9[9]Elshourbagy NA, Douglas SA, Shabon U, et al. Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey[J]. Br J Pharmacol,2002,136(1):9-22.
  • 10[10]Douglas SA, Sulpizio AC, Piercy V, et al. Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey[J]. Br J Pharmacol,2000,131(7):1262-1274.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部